Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment

BACKGROUND: There is limited information on innate immunity, especially natural killer (NK) cell function, in different chronic hepatitis B (CHB) stages. Therefore, we examined whether the clinical staging strategy accurately reflects veritable NK cell immunity. METHODS: A total of 237 eligible CHB...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyan, Zhou, Liang, Gu, Lin, Gu, Yurong, Chen, Lubiao, Lian, Yifan, Huang, Yuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663047/
https://www.ncbi.nlm.nih.gov/pubmed/29089040
http://dx.doi.org/10.1186/s12967-017-1318-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663047/
https://www.ncbi.nlm.nih.gov/pubmed/29089040
http://dx.doi.org/10.1186/s12967-017-1318-1

Ejemplares similares